Seroprevalence of Entamoeba histolytica infection in China

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 1, 2012, Pages 97-103

  Yang, Bin ^a   Chen, Yingdan ^b   Wu, Liang ^a   Xu, Longqi ^b   Tachibana, Hiroshi ^c   Cheng, Xunjia ^a  

^a FUDAN UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN;

ADOLESCENT; ADULT; AGED; AMEBIASIS; ARTICLE; BLOOD SAMPLING; CHILD; CHINA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MAXIMUM LIKELIHOOD METHOD; SCHOOL CHILD; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CHILD; CHINA; DNA PRIMERS; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

ENTAMOEBA HISTOLYTICA;

EID: 84863768438     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0626     Document Type: Article

References (41)

1. 1997. WHO/PAHO/UNESCO report. A consultation with experts on amoebiasis. Mexico City, Mexico, January 28-29, 1997. Epidemiol Bull 18: 13-14.
2. Guerrant RL, 1986. Amebiasis: introduction, current status, and research questions. Rev Infect Dis 8: 218-227.
3. Stauffer W, Ravdin JI, 2003. Entamoeba histolytica: an update. Curr Opin Infect Dis 16: 479-485. (Pubitemid 37267268)
4. Diamond LS, Clark CG, 1993. A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol 40: 340-344.
5. Sen A, Chatterjee NS, Akbar MA, Nandi N, Das P, 2007. The 29-kilodalton thiol-dependent peroxidase of Entamoeba histolytica is a factor involved in pathogenesis and survival of the parasite during oxidative stress. Eukaryot Cell 6: 664-673. (Pubitemid 46697547)
6. Samie A, Obi LC, Bessong PO, Stroup S, Houpt E, Guerrant RL, 2006. Prevalence and species distribution of E. histolytica and E. dispar in the Venda region, Limpopo, South Africa. Am J Trop Med Hyg 75: 565-571. (Pubitemid 46941327)
7. Tanyuksel M, Petri WA, 2003. Laboratory diagnosis of amebiasis. Clin Microbiol Rev 16: 713-729. (Pubitemid 37296557)
8. Salit IE, Khairnar K, Gough K, Pillai DR, 2009. A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain. Clin Infect Dis 49: 346-353.
9. Walsh JA, 1986. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 8: 228-238.
10. Ramos F, Moran P, Gonzalez E, Garcia G, Ramiro M, Gomez A, de Leon Mdel C, Melendro EI, Valadez A, Ximenez C, 2005. High prevalence rate of Entamoeba histolytica asymptomatic infection in a rural Mexican community. Am J Trop Med Hyg 73: 87-91. (Pubitemid 41278754)
11. Stauffer W, Abd-Alla M, Ravdin JI, 2006. Prevalence and incidence of Entamoeba histolytica infection in South Africa and Egypt. Arch Med Res 37: 266-269. (Pubitemid 43003630)
12. Stanley SL Jr, 2003. Amoebiasis. Lancet 361: 1025-1034.
13. van Hal SJ, Stark DJ, Fotedar R, Marriott D, Ellis JT, Harkness JL, 2007. Amoebiasis: current status in Australia. Med J Aust 186: 412-416. (Pubitemid 46691862)
14. Yu SH, Xu LQ, Jiang ZX, Xu SH, Han JJ, Zhu YG, Chang J, Lin JX, Xu FN, 1994. Report on the first nationwide survey of the distribution of human parasites in China. Chin J Parasitol Parasitic Dis 12: 241-247.
15. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr, 2003. Amebiasis. N Engl J Med 348: 1565-1573. (Pubitemid 36437934)
16. Tachibana H, Kobayashi S, Nagakura K, Kaneda Y, Takeuchi T, 2000. Asymptomatic cyst passers of Entamoeba histolytica but not Entamoeba dispar in institutions for the mentally retarded in Japan. Parasitol Int 49: 31-35. (Pubitemid 30151156)
17. Zhang Y, Li E, Jackson TF, Zhang T, Gathiram V, Stanley SL Jr, 1992. Use of a recombinant 170-kilodalton surface antigen of Entamoeba histolytica for serodiagnosis of amebiasis and identification of immunodominant domains of the native molecule. J Clin Microbiol 30: 2788-2792.
18. Soong CJ, Torian BE, Abd-Alla MD, Jackson TF, Gatharim V, Ravdin JI, 1995. Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen. Infect Immun 63: 472-477.
19. Tachibana H, Cheng XJ, Masuda G, Horiki N, Takeuchi T, 2004. Evaluation of recombinant fragments of Entamoeba histolytica Gal/GalNAc lectin intermediate subunit for serodiagnosis of amebiasis. J Clin Microbiol 42: 1069-1074. (Pubitemid 38332827)
20. Diamond LS, Harlow DR, Cunnick CC, 1978. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72: 431- 432.
21. Cheng XJ, Hughes MA, Huston CD, Loftus B, Gilchrist CA, Lockhart LA, Ghosh S, Miller-Sims V, Mann BJ, Petri WA Jr, Tachibana H, 2001. Intermediate subunit of the Gal/GalNAc lectin of Entamoeba histolytica is a member of a gene family containing multiple CXXC sequence motifs. Infect Immun 69: 5892-5898. (Pubitemid 32786530)
22. Petri WA Jr, Chapman MD, Snodgrass T, Mann BJ, Broman J, Ravdin JI, 1989. Subunit structure of the galactose and N-acetyl- D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. J Biol Chem 264: 3007-3012. (Pubitemid 19057803)
23. Petri WA Jr, Schnaar RL, 1995. Purification and characterization of galactose- and N-acetylgalactosamine-specific adhesin lectin of Entamoeba histolytica. Methods Enzymol 253: 98-104.
24. Cheng XJ, Tsukamoto H, Kaneda Y, Tachibana H, 1998. Identification of the 150-kDa surface antigen of Entamoeba histolytica as a galactose- and N-acetyl-D-galactosamine-inhibitable lectin. Parasitol Res 84: 632-639. (Pubitemid 28370752)
25. Hosmer D, Lemeshow S, 2000. Applied Logistic Regression. Second edition. New York: Wiley.
26. Zheng YL, 1986. An epidemiologic survey on Endoameba histolytica infection. Zhonghua Liu Xing Bing Xue Za Zhi 7: 274-276.
27. Zhang TH, 1988. Seroepidemiological study on amoebiasis. Zhonghua Liu Xing Bing Xue Za Zhi 9: 217-219.
28. Haque R, Neville LM, Wood S, Petri WA Jr, 1994. Short report: detection of Entamoeba histolytica and E. dispar directly in stool. Am J Trop Med Hyg 50: 595-596. (Pubitemid 24196348)
29. Rivera WL, Tachibana H, Silva-Tahat MR, Uemura H, Kanbara H, 1996. Differentiation of Entamoeba histolytica and E. dispar DNA from cysts present in stool specimens by polymerase chain reaction: its field application in the Philippines. Parasitol Res 82: 585-589. (Pubitemid 26265853)
30. Hamzah Z, Petmitr S, Mungthin M, Leelayoova S, Chavalitshewinkoon-Petmitr P, 2010. Development of multiplex realtime polymerase chain reaction for detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in clinical specimens. Am J Trop Med Hyg 83: 909-913.
31. Nunez YO, Fernandez MA, Torres-Nunez D, Silva JA, Montano I, Maestre JL, Fonte L, 2001. Multiplex polymerase chain reaction amplification and differentiation of Entamoeba histolytica and Entamoeba dispar DNA from stool samples. Am J Trop Med Hyg 64: 293-297.
32. Shenai BR, Komalam BL, Arvind AS, Krishnaswamy PR, Rao PV, 1996. Recombinant antigen-based avidin-biotin microtiter enzyme-linked immunosorbent assay for serodiagnosis of invasive amebiasis. J Clin Microbiol 34: 828-833. (Pubitemid 26091491)
33. Abd-Alla MD, Jackson TG, Ravdin JI, 1998. Serum IgM antibody response to the galactose-inhibitable adherence lectin of Entameoba histolytica. Am J Trop Med Hyg 59: 431-434. (Pubitemid 28429086)
34. Stanley SL Jr, Jackson TF, Foster L, Singh S, 1998. Longitudinal study of the antibody response to recombinant Entamoeba histolytica antigens in patients with amebic liver abscess. Am J Trop Med Hyg 58: 414-416. (Pubitemid 28183249)
35. Chen Y, Zhang Y, Yang B, Qi T, Lu H, Cheng X, Tachibana H, 2007. Seroprevalence of Entamoeba histolytica infection in HIV-infected patients in China. Am J Trop Med Hyg 77: 825-828. (Pubitemid 351837823)
36. Li E, Stanley SL, 1996. Protozoa. Amebiasis. Gastroenterol Clin North Am 25: 471-492. (Pubitemid 26335819)
37. Batchelor NA, Atkinson PM, Gething PW, Picozzi K, Fevre EM, Kakembo ASL, Welburn SC, 2009. Spatial predictions of Rhodesian human African trypanosomiasis (sleeping sickness) prevalence in Kaberamaido and Dokolo, two newly affected districts of Uganda. PLoS Negl Trop Dis 3: e563.
38. Wardrop NA, Atkinson PM, Gething PW, Fevre EM, Picozzi K, Kakembo AS, Welburn SC, 2010. Bayesian geostatistical analysis and prediction of Rhodesian human African trypanosomiasis. PLoS Negl Trop Dis 4: e914.
39. Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, Noor AM, Kabaria CW, Manh BH, Elyazar IR, Brooker S, Smith DL, Moyeed RA, Snow RW, 2009. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6: e1000048.
40. Craig MH, Sharp BL, Mabaso ML, Kleinschmidt I, 2007. Developing a spatial-statistical model and map of historical malaria prevalence in Botswana using a staged variable selection procedure. Int J Health Geogr 6: 44.
41. Clements AC, Lwambo NJ, Blair L, Nyandindi U, Kaatano G, Kinung'hi S, Webster JP, Fenwick A, Brooker S, 2006. Bayesian spatial analysis and disease mapping: tools to enhance planning and implementation of a schistosomiasis control programme in Tanzania. Trop Med Int Health 11: 490 -503.